Arglabin

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameArglabin
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionProtein farnesyltransferase inhibitors
TargetsProtein farnesyltransferase
Therapy Area/IndicationsLung NeoplasmsLiver NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesInstitute Of Phytochemistry
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsLung NeoplasmsLiver NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeL01
Related LinksWikipedia